Latest Breaking News On - Brii biosciences limited bio - Page 3 : comparemela.com

Brii Biosciences Announces Top-line Results from Phase 1 Study of BRII-296, A Long-Acting Therapy in Development for Postpartum Depression

/PRNewswire/ Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a multi-national company developing innovative therapies for.

City ofUnited kingdomJi maBrii bioAleksandar skubanPreclinical developmentInternational marcBrii biosciences limited bioSociety conferenceBrii biosciences limitedVice presidentClinical pharmacologyTherapy area headHealthy adult subjectsUnited kingdomseptemberDepo medrol

Brii Biosciences Provides Corporate Update and Reports 2022 Interim Results

Brii Biosciences Provides Corporate Update and Reports 2022 Interim Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongKarend neuendorffZhi hongNanshan zhongBrii bioAleksandar skubanVir biotechnology incCentral nervous system disease programNational health commission of chinaCure program chinaBrii biosciences limited bioVaccines incTherapeutics ltd beijing coProgram chinaTherapeutics inc

Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Live Omicron

Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Live Omicron
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBrii bioDavid margolisUniversity of marylandNational health commission of chinaNational institute of allergyUs national institutes of healthBrii biosciences limited bioDrug administrationBrii biosciencesNational medical products administrationTsinghua universityEmergency use authorizationBrii biosciences limitedNational instituteInfectious diseases

Brii Bio Announces Strategic Partnership with China Resources Pharmaceutical Commercial Group to Advance the Commercialization of Long-acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Ro

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in ChinaThe amu.

United statesBrii bioRogers luoTherapeutics beijing co ltdChina resources pharmaceutical groupNational health commission of chinaNational institute of allergyUs national institutes of healthBrii biosciences limited bioChina resources groupChina resources pharmaceutical commercial group co ltdNational medical products administrationTsinghua universityChinaon julyBrii biosciences limitedNational health commission

Brii Biosciences Appoints Dr Susannah Cantrell as Chief Business Officer

Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer - read this article along with other careers information, tips and advice on BioSpace

United statesZhi hongBrii bioGenentech rocheSusannah cantrellBrii biosciences limited bioUniversity of missouriWestminster collegeMarketing oncology at gilead sciencesCompany codesPrnewswire brii biosciences limited bioBrii biosciencesBiosciences limitedChief businessChief executive officerChief operating officer